A LiquidPlanner alternative built for R&D schedule risk

LiquidPlanner pioneered priority-driven, probabilistic scheduling — but it is general-purpose PPM with no CPM, CCPM, TOC, decision gates, AACE compliance, or chat AI. CritPath AI brings the full method stack plus a schedule-grounded copilot to R&D programs.

Last updated: July 2026

LiquidPlanner (now part of Tempo) is one of the few mainstream PM tools that took probabilistic scheduling seriously. Its predictive engine runs a priority-driven Monte Carlo over your task list, ranged estimates, and resource availability to produce confidence-banded finish dates and portfolio-wide leveling — genuinely ahead of the deterministic Gantt crowd. For dependency-heavy teams that juggle many projects against shared people, that is a real and uncommon capability.

But LiquidPlanner is general-purpose PPM. It models priority and effort, not the schedule-risk methods an R&D program leans on. There is no critical path method, no critical chain or Theory of Constraints, no decision gates, no AACE compliance, and no chat AI that reasons over your dependency graph. If you run a biotech IND timeline, a deep-tech hardware build, or a federally funded research program, you need that math — and a copilot that can explain it. CritPath AI delivers the full method stack (CPM + CCPM/TOC + Monte Carlo), gates, AACE 132R-23 Level 4, and a schedule-grounded AI copilot in a web app at $10/user/month.

CapabilityCritPath AILiquidPlanner
Probabilistic schedulingYes — PERT-Beta Monte Carlo over a CPM network, P50/P80/P90, risk-event injection, optional correlationYes — priority-driven Monte Carlo over effort ranges, confidence-banded dates (its core strength)
Critical Path Method (CPM)Yes — 4 dependency types, lag, float, near-critical analysisNo — priority-driven engine, not formal CPM
CCPM / TOC / Drum-Buffer-RopeYes — critical chain, project + feeding buffers, fever chart, DBRNo — not supported
Criticality index / tornado sensitivityYes — criticality index and tornado tied to the dependency networkNo — confidence bands, but no CPM-based sensitivity
Decision gates with retroactive reschedulingYes — Go/No-Go/Pivot/Defer gates that re-cascade the scheduleNo — not supported
AACE 132R-23 Level 4 + audit trailYes — risk-driven scheduling with an append-only audit logNo — general PPM, no AACE compliance
Schedule-aware AI copilotYes — Claude + Gemini, grounded in the live dependency graphNo chat copilot — predictive engine only
Portfolio resource levelingYes — resource-feasible leveling view; resource map maturingYes — mature, portfolio-wide priority-driven leveling (a real strength)
R&D-native (biotech / deep-tech / federal)Yes — built for IND timelines, TRL gates, AACE/federal rigorNo — horizontal, general-purpose PPM
Price$10/user/month (AI usage billed separately, metered)~$15–$42/user/month reportedly, tier-based (quote for current pricing)

Where LiquidPlanner is genuinely strong

LiquidPlanner's standout is its predictive scheduling engine. Unlike the deterministic Gantts that most PM tools ship, it asks for ranged (best-case / worst-case) estimates and runs a priority-driven Monte Carlo across the portfolio, surfacing confidence-banded finish dates instead of a single optimistic line. That is the honest answer to 'when will this actually land,' and few horizontal tools attempt it.

It also does portfolio-wide resource leveling well: tasks flow to people by priority, and the engine continuously re-forecasts as availability and ranges change. For mid-market to enterprise teams running many interdependent projects against a shared resource pool, LiquidPlanner's automatic, priority-ordered scheduling is a mature and legitimately useful capability that newer tools should respect, not dismiss. Its reported pricing — roughly $15/user/month at entry up to about $42/user/month at the top tier — is reasonable for general PPM.

Where LiquidPlanner falls short for R&D schedule risk

The gap is methodological, not cosmetic. LiquidPlanner's Monte Carlo is priority-driven over effort ranges — it is not a CPM-based quantitative schedule risk analysis. There is no formal critical path with four dependency types, lag, and float; no critical chain, Theory of Constraints, or Drum-Buffer-Rope buffers; no criticality index or tornado sensitivity tied to a dependency network; and no AACE RP 132R-23 Level 4 risk-driven scheduling. For a board deck that needs a defensible P50/P80 date, or a federal program that must show AACE-grade rigor, those absences matter.

It also has no decision gates — the Go/No-Go/Pivot/Defer checkpoints that govern real R&D programs — and therefore no retroactive rescheduling when a gate flips or a CMC vendor slips. And while its predictive engine reasons about schedule, there is no conversational AI copilot grounded in your actual graph: nothing you can ask 'which task is driving my P80 slip, and what does deferring gate 2 do downstream.' LiquidPlanner is excellent general PPM; it was never built to be an R&D schedule-risk platform.

  • No formal CPM (no 4 dependency types, lag, float, near-critical analysis).
  • No CCPM, Theory of Constraints, or Drum-Buffer-Rope buffers / fever chart.
  • No decision gates or retroactive rescheduling.
  • No AACE 132R-23 Level 4 compliance or risk-driven scheduling outputs.
  • No chat AI copilot grounded in the dependency graph — predictive engine only.
  • General-purpose PPM, not R&D-native (biotech / deep-tech / federal).

What CritPath AI does instead

CritPath AI keeps the spirit of probabilistic scheduling and builds the full method stack underneath it. Its Monte Carlo engine runs PERT-Beta distributions with risk-event injection, criticality index, tornado sensitivity, optional duration correlation, and P50/P80/P90 finish dates — tied to a real Critical Path Method model (four dependency types, lag, float, near-critical analysis), not just an effort ranking. On top of that it layers CCPM with Theory of Constraints and Drum-Buffer-Rope (drum, project and feeding buffers, fever chart), decision gates with retroactive rescheduling, WSJF and Cost of Delay, and EVM (SPI/CPI/EAC).

All of it carries AACE RP 132R-23 Level 4 risk-driven scheduling with an append-only audit log, and all of it runs in a browser with multi-tenant orgs, 2FA, XLSX/CSV import, and AI work-breakdown decompose. The differentiator LiquidPlanner cannot match is the AI copilot: built on Claude and Gemini and grounded in your live dependency graph, it can tell you which task drives your P80 slip and what a gate decision does downstream — reasoning over the actual engine, not predicting from effort data alone. (During the beta, autonomous AI-agent runs are off; AI assistance — coach, decompose, reports, skill wizards — is on.)

LiquidPlanner vs. CritPath AI

The table below compares the two on the capabilities that decide an R&D schedule-risk purchase. LiquidPlanner pricing is reportedly tier-based (roughly $15 entry to about $42 at the top) and is quoted here for orientation only; refresh against current vendor pricing.

Which should you choose?

If you run a broad portfolio of interdependent projects against a shared resource pool — agencies, IT, services teams — and your main need is automatic, priority-driven scheduling with confidence bands, LiquidPlanner's mature predictive engine and portfolio leveling are a legitimate fit. CritPath does not claim to out-PPM LiquidPlanner on that horizontal ground today.

But if you run R&D programs and need real CPM, CCPM buffers, TOC constraints, and decision gates that re-cascade the schedule — plus AACE 132R-23 Level 4 rigor and an AI copilot that explains why a date moved — CritPath AI occupies a quadrant LiquidPlanner does not reach. You get rigorous, R&D-native schedule-risk math with modern UX and a schedule-aware copilot, at $10/user/month with AI usage metered separately.

Frequently asked questions

Does CritPath AI do predictive scheduling like LiquidPlanner?

Yes, and it goes further. LiquidPlanner runs a priority-driven Monte Carlo over effort ranges. CritPath runs PERT-Beta Monte Carlo over a real CPM dependency network — with risk-event injection, criticality index, tornado sensitivity, optional duration correlation, and P50/P80/P90 dates — then layers CCPM buffers, TOC constraints, and decision gates LiquidPlanner does not have.

What does CritPath AI have that LiquidPlanner doesn't?

Formal CPM (four dependency types, lag, float, near-critical analysis), CCPM with Theory of Constraints and Drum-Buffer-Rope, decision gates with retroactive rescheduling, WSJF and Cost of Delay, EVM, AACE RP 132R-23 Level 4 risk-driven scheduling, and an AI copilot grounded in your live dependency graph. LiquidPlanner is general-purpose PPM and ships none of these.

How much does LiquidPlanner cost vs. CritPath AI?

LiquidPlanner is reportedly tier-based — roughly $15/user/month at entry up to about $42/user/month at the top tier; confirm current pricing with the vendor. CritPath AI is $10/user/month with every standard feature and unlimited projects, with AI copilot usage billed separately by metered token usage.

Is LiquidPlanner good for biotech or deep-tech R&D programs?

LiquidPlanner is strong general PPM for dependency-heavy portfolios, but it is not R&D-native. It lacks CPM, CCPM/TOC, decision gates, and AACE compliance — the methods biotech IND timelines, deep-tech TRL gates, and federally funded programs depend on. CritPath AI is built specifically for those programs.

Can CritPath AI replace LiquidPlanner for portfolio resource leveling?

CritPath offers a resource-feasible leveling view alongside its scheduling engine, and its resource map is maturing. LiquidPlanner's portfolio-wide, priority-driven leveling is more mature in that specific lane today. Where CritPath wins decisively is schedule-risk math, gates, AACE compliance, and a schedule-aware AI copilot.

Related

See the math on your own schedule

CritPath AI is $10/user/month — real Monte Carlo, CCPM, decision gates, and a schedule-aware AI copilot. Join the waitlist for beta access.

Join the waitlist